Today's Paper Digital FAQ Obits River Valley Democrat-Gazette Newsletters 🎄Community Christmas Card NWA Screening Sites NWA Vaccine Information Virus Interactive Map Coronavirus FAQ Crime Razorback Sports Today's Photos Puzzles

Walmart adds insulin product to offerings

by Serenah McKay | November 24, 2021 at 12:39 p.m.
A sign at a Walmart store is pictured Thursday, June 24, 2021, in Oklahoma City. Walmart Inc.on Tuesday, Nov. 16, reported fiscal third-quarter net income of $3.11 billion. On a per-share basis, the Bentonville, Arkansas-based company said it had profit of $1.11. (AP Photo/Sue Ogrocki)

Walmart Inc. has added a new insulin product to its more affordable private-label brand for diabetes management, the company said Tuesday.

ReliOn NovoLog Mix 70/30 combines a fast-acting insulin to control mealtime blood sugar spikes with an "intermediate" insulin that helps control blood sugar between meals, Walmart said in a blog post.

People with either Type 1 or Type 2 diabetes can use the injectable product available at all Walmart and Sam's Club pharmacies.

At $72.88 per vial and $85.88 for five FlexPens, ReliOn's version can save customers between 58% and 75% off the cash price of branded analog insulin, Walmart said.

Analog insulin is a lab-grown version of the human hormone, genetically altered for better performance, according to the Juvenile Diabetes Research Foundation.

Michael Burke, director of brand pharmacy merchandising for Walmart's health and wellness unit, said in the blog post that the retailer worked with insulin manufacturer Novo Nordisk to develop the product.

In June, the Bentonville-based retailer introduced what it said is the first private-label insulin, NovoLog.


Sponsor Content